The Standard Formula: A Guide to Solvency II – Chapter 7: Technical Provisions

Skadden Publication

Robert A. Chaplin Ben Lyon Feargal Ryan Mary S. Bonsu Theodoulos Charalambous

See all chapters of A Guide to Solvency II.

Introduction

“The value of technical provisions shall correspond to the current amount insurance and reinsurance undertakings would have to pay if they were to transfer their insurance and reinsurance obligations immediately to another insurance or reinsurance undertaking.”417

A (re)insurer must hold assets to meet its ongoing obligations to policyholders, which requires a forward-looking assessment of all relevant cash flows over the expected duration of the liabilities in question, subject to a risk margin.418 This assessment results in a net amount that must be held in assets that are appropriate to the nature and duration of the liabilities. These are referred to as “technical provisions”.

Technical provisions are not to be confused with a (re)insurer’s capital requirements comprised of the SCR and MCR. The SCR (and MCR) sits as a buffer on top of technical provisions to guard against adverse deviation in market, operating, or other conditions on at least a 1 in 200 basis. Equally, technical provisions are not to be confused with “own funds”, being the capital items with which a (re)insurer must cover its capital requirements (or the assets in which a (re)insurer may invest the proceeds of such own-funds items). These different concepts and regimes are covered in other chapters.

As such, technical provisions are typically the largest item on a (re)insurer’s balance sheet. The methodology for calculating technical provisions is based on various factors, including expected future cash flows, potential risks and regulatory requirements taking into account the specific risk profile of each insurer.

Following Brexit, the UK’s divergence from EU-derived rules includes liberalisation of the EU Solvency II regime towards a new Solvency UK, moving the UK back toward a less prescriptive and more principles-based regulatory rule set. The UK divergence from the EU Solvency II regime has also affected technical provisions, specifically the risk margin and MA. We expect the PRA to continue to develop these areas of divergence in the coming years. In this chapter, we summarise the Solvency II position, together with the UK approach (to the extent different or otherwise noteworthy).

For its part, the EU has also revisited technical provisions as part of the 2020 Review, with the EIOPA proposing “improvements” to:

  • The VA to better align the design to its objectives and increase its effectiveness in curbing short-term volatility and rewarding insurers for holding illiquid liabilities.
  • The calculation of the risk margin of insurance liabilities, recognising diversification over time, thus reducing its volatility and size, in particular for long-term liabilities.

The key requirements for technical provisions are detailed in Articles 76 to 86 of the Solvency II Directive, Articles 48 to 69 of the Level 2 Delegated Regulation and the Technical Provisions part of the PRA Rulebook. These are supplemented by (in the EU) the EIOPA Level 3 Guidelines and (in the UK) various PRA SSs,419 which clarify the same or provide the PRA’s views where the regulations or subsidiary legislation are unclear.

Skadden | The Standard Formula Podcast - Click Here to Listen

1. The Best Estimate of Liabilities

The main component of the technical provisions is the BEL. This represents the amount needed at the valuation date to discharge all insurance liabilities, together with all future expenses that will be incurred in managing the business until its expiry (or contract boundaries if sooner, described below).

The BEL corresponds to the probability-weighted average of future cash flows, taking into account the time value of money (expected present value of future cash flows) using the relevant RFR term structure (see below).420 It must be calculated:

  • Based on up-to-date and credible information and realistic assumptions.
  • Using adequate, applicable and relevant actuarial and statistical methods.
  • As a gross value, without deduction of the amounts recoverable from reinsurance contracts and UK ISPVs, which firms must calculate separately.421

Cash Flows

The cash flow projection used in the calculation of the best estimate (whether valued separately or determined on the basis of financial instruments, as described below) must take into account all the cash in- and out-flows required to settle the (re)insurance obligations over their lifetime.422

The general rule is that cash flows related to an insurance contract should be included from the earlier of the date the (re)insurer becomes a party to the agreement or the date the insurance or reinsurance cover starts (the recognition date). Such cash flows should include the following related to existing insurance and reinsurance contracts:

  • Benefit payments to policyholders and beneficiaries.
  • Payments incurred by the (re)insurer to provide contractual benefits in kind.
  • Payments of certain expenses.
  • Premium payments and any additional cash flows resulting from those premiums.
  • Payments between the (re)insurer and intermediaries related to (re)insurance obligations.
  • Payments between the (re)insurer and investment firms concerning contracts with index-linked and unit-linked benefits.
  • Payments for salvage and subrogation to the extent they do not qualify as separate assets or liabilities under applicable international accounting standards (IASs).
  • Taxation payments charged to policyholders or required to settle (re)insurance obligations.423

The cash flows must also account for, either explicitly or implicitly:

  • All uncertainties, including timing, claim amounts, expenses and policyholder behaviour.424
  • Administrative, investment management, claims management and acquisition expenses.425
  • Expected future developments outside the undertaking’s control if these would materially impact cash flows over the policy’s lifetime.
  • Any financial guarantees and contractual options included in their (re)insurance policies, including the factors that may affect the likelihood that policyholders will exercise those contractual options or realise the value of financial guarantees.426 
  • The cost of hedging any embedded options and guarantees.427

Assumptions

While actuarial and statistical methods used to calculate the cash flows are not prescribed, the methodology and its results must be reviewable by a qualified expert.428 However, these are based on a number of assumptions that may not be realised in the future. For example, material variances in premiums may be caused by factors such as changes in lapse/surrender rates, or changes in ceding company retentions which may be permitted under some treaties. The use of assumptions means that the BEL is at best an estimate, and the future outcome is likely to vary from the estimate. A great deal of time and effort goes into selecting assumptions that are viewed as being the best available.

Future Management Actions

(Re)insurers are also permitted to make certain assumptions relating to future management actions and, as such, effectively reduce the potential future liabilities or cash flows. These assumptions may only be taken into account if they are realistic, i.e.:

  • Determined in an objective manner.
  • Consistent with the current business practise and strategy.
  • Consistent with each other.
  • Not contrary to any obligations toward policyholders or legal requirements.
  • Consistent with any public indications of what the future management actions may be.429

Discounting Using Risk-Free Interest Rate Term Structure

The BEL accounts for the fact that some liabilities only need to be met in the future, and returns can be earned on invested premiums in the meantime. Hence, in calculating the BEL, investment income on the assets associated with the BEL is taken into account, but based on “risk-free” assets, which are assets for which the risk of default is negligible, typically government bonds.430

The BEL is therefore calculated by projecting future cash flows and discounting them back to the valuation date at the RFR. The RFR is not a simple rate of interest but a set of rates for each year in the future (an interest rate “curve”). The derivation of this curve is complex and beyond the scope of this chapter. However, (re)insurers must ensure that the RFR:

  • Is determined using, and consistent with, information derived from relevant financial instruments.
  • Takes into account relevant financial instruments of those maturities where the markets for those financial instruments, as well as for bonds, are deep, liquid and transparent.
  • Is only extrapolated for maturities where the markets for the relevant financial instruments or for bonds are not deep, liquid and transparent. This shall be based on forward rates converging smoothly from one set of forward rates in relation to the longest maturities for which the relevant financial instrument and the bonds can be observed in a deep, liquid and transparent market to an ultimate forward rate (UFR).431

The Amendments (discussed in previous chapters) will introduce a new method for extrapolation of the RFR. Under this new method, extrapolation will start from a First Smoothing Point (FSP) i.e., the point at which bond markets are no longer considered deep, liquid or transparent, which is set at a maturity of 20 years for the Euro.432 The extrapolation will be based on forward rates converging smoothly from the applicable forward rate at the FSP to a UFR.433 The Amendments provide for a phasing-in mechanism for this new extrapolation method, use of which will be subject to prior supervisory approval434 This will allow for the new extrapolation method to be phased in linearly between the implementation date of the Amendments and 1 January 2032, during which period (re)insurers must publicly disclose (as part of their SFCR) the impact of not applying the phase-in mechanism on their financial position.435

The RFR is calculated for each currency and maturity.436 The EIOPA publishes the relevant RFR information for EU (re)insurers (including the EU subsidiaries of UK (re)insurance groups). The PRA publishes the equivalent information for UK (re)insurers.

The PRA determines its relevant currencies based on the materiality of technical provisions denominated in each currency and the currencies for which UK insurers are authorised to use the VA or the MA. The PRA will periodically review the list of relevant currencies.

If a UK insurer has technical provisions in a currency for which the PRA does not publish technical information, the (re)insurer must propose TI that complies with Solvency II requirements and justify this approach to its supervisor.

2. The Risk Margin

The risk margin covers the (re)insurer’s need to hold capital against non-hedgeable risks. This requires a projection of the solvency capital, so as to ensure that the value of the technical provisions is equivalent to the amount that another (re)insurer would be expected to require in order to take over and meet the relevant (re)insurance liabilities over their lifetime.437 This is determined using a cost of capital rate438 (to be added to the RFR to give the total return for the putative acquiror) using a prescribed formula/method.439

Solvency II sets the cost of capital rate at 6%.440 Widely viewed as too high, the UK has reduced this to 4% for both life and non-life companies as part of the transition from Solvency II to Solvency UK,441 with the result that the overall risk margin has reduced in the UK by around 65% for long-term life businesses and 30% for non-life businesses. As part of its review of Solvency II, the EIOPA had proposed to reduce the cost of capital rate to 4.75%, again for both life and non-life companies. One of the Amendments to the Solvency II Directive (that has not yet taken effect) acts upon the advice of the EIOPA and reduces the cost of capital rate from 6% to 4.75%.442

The risk margin calculation is based on various assumptions:

  • The entire portfolio of insurance and reinsurance obligations of the original undertaking is taken over by a reference undertaking.
  • If the original undertaking engages in both life and non-life insurance activities, these portfolios are taken over separately by different reference undertakings.
  • The transfer includes any reinsurance contracts and arrangements with SPVs related to these obligations.
  • The reference undertaking has no preexisting insurance or reinsurance obligations or own funds before the transfer.
  • Post-transfer, the reference undertaking:
    • Assumes no new insurance or reinsurance obligations.
    • Raises eligible own funds equal to the SCR necessary to support the obligations over their lifetime.
    • Has assets equal to the sum of its SCR and technical provisions net of amounts recoverable from reinsurance contracts and SPVs.
  • Assets are selected to minimise the SCR for market risk.
  • The SCR of the reference undertaking includes:
    • Underwriting risk of the transferred business.
    • Material market risk, excluding interest rate risk.
    • Credit risk related to reinsurance contracts, SPVs, intermediaries, policyholders, and other related exposures.
    • Operational risk.
  • The loss-absorbing capacity of technical provisions in the reference undertaking matches that in the original undertaking for each risk.
  • There is no loss-absorbing capacity of deferred taxes.
  • The reference undertaking adopts future management actions consistent with those assumed by the original undertaking.443

Generally, the BEL and the risk margin are calculated separately. In the case of, for example, index-linked life insurance, a (re)insurer may calculate them together if the cash flows of the (re)insurance obligations can be reliably replicated by a financial instrument444 provided that it is traded on an active, deep, liquid and transparent market to ensure a valid market value.445 In such cases, the market value of the relevant financial instrument determines technical provisions for those future cash flows.

3. Contract Boundaries

Under Solvency II, a (re)insurer should stop recognising cash flows under an insurance contract when its obligations end.446 In other words, only obligations within the contract boundary should be recognised. Contract boundary refers to the term of the insurance contract over which premiums and benefits are guaranteed.

In many cases, the boundary will be the same as the term of the contract, but if the (re)insurer has the right to increase premiums or vary benefits before the contract ends, the contract boundary is the point at which that right can be exercised. It is not enough simply to be able to increase premiums to establish a contract boundary. It is defined in the Solvency II regulations as “… the future date where the insurance or reinsurance undertaking has a unilateral right to amend the premiums or the benefits payable under the contract in such a way that the premiums fully reflect the risks”.447 This means that the insurer must be able to increase premiums sufficiently to cover the risks insured. Further, the insurer must have the right to compel the policyholder to pay the premiums for the risks undertaken, including any future date when the (re)insurer has a unilateral right to terminate the contract or has a unilateral right to reject premiums under the contract.448

The test can be applied at the portfolio level rather than the individual contract level, with limited exceptions. When assessed at the portfolio level, insurers should consider whether the premiums or benefits of the portfolio can be adjusted so that the premiums fully reflect the risks covered. This is valid only if no circumstances would cause the benefits and expenses to exceed the premiums. If the (re)insurer has a unilateral right that applies to only part of the contract, the same principles apply to that part.

4. The Matching Adjustment

Long-term insurance products, such as annuities, are typically backed by insurers with long-term assets that match the cash flows closely (such as long-dated bonds) and are expected to be held to maturity.

Where an insurer holds, for example, a bond to maturity, it is exposed only to the default of the issuer in paying the coupon and/or redeeming the principal amount. In other words, it can effectively disregard changes to market value (other than those that reflect default risk) between acquisition and maturity of the asset. This is sometimes referred to as an “illiquidity premium”. The MA is the mechanism that delivers this illiquidity premium to (re)insurers.

The detail of this mechanism resides in the calculation of technical provisions and, specifically, the discount rate that is applied to take account of the time value of money. The MA is an adjustment to that discount rate, allowing the insurer to use a discount rate closer to the credit-adjusted market rate of return for the relevant liabilities instead of the RFR prescribed by Solvency II (see above). This higher discount rate lowers the present value of liabilities and, consequently, lowers the technical provisions of the (re)insurer. In other words, the illiquidity premium is delivered by means of a synthetic reduction in an insurer’s capital requirements.

More detailed information about the MA, together with the PRA’s reforms under Solvency UK, can be found in Chapter 5: The Matching Adjustment.

5. The Volatility Adjustment

Similar to the MA, the VA modifies the RFR for each relevant currency but with the purpose of allowing a (re)insurer to smooth the balance sheet impact of volatility in financial markets.449 This in turn prevents pro-cyclical investment behaviour.

The PRA considers that the VA achieves this by preventing the requirement for market-consistent valuation of assets and liabilities under Solvency II from disincentivising insurers from investing in assets that would otherwise be appropriate for the insurer to hold, taking into account the nature and duration of their insurance liabilities. The VA therefore aims to mitigate artificial balance sheet volatility caused by short-term market volatility in the value of assets arising from the exaggerations of bond spreads by allowing insurers to reflect movements to those asset prices within the market-consistent valuation of the corresponding liabilities.

The VA is calculated based on the spread between the interest rate from the reference portfolio assets and the relevant RFR for that currency.450 The calculation follows a formula in Article 50 of the Level 2 Delegated Regulation, referring to the “risk-corrected currency spread”, being the difference between the calculated spread and the portion attributable to expected losses or unexpected credit risks. This adjustment is based on a risk-corrected spread of assets in a reference portfolio, calculated by the EIOPA for EU member states451 (and by the PRA for UK insurers)452 on a currency and country basis at least quarterly.

The VA may not be used alongside the MA — only one may be used for a given portfolio of liabilities (noting that in the UK, a firm may apply for the VA as a contingency if its MA application is rejected).453

In the UK, a (re)insurer must apply to the PRA for approval to use the VA and satisfy three conditions ahead of approval:

  • Condition 1: The VA is correctly applied to the relevant RFR term structure in order to calculate the best estimate.
  • Condition 2: The firm does not breach a relevant requirement as a result or consequence of applying the VA.
  • Condition 3: The application of the VA does not create an incentive for the undertaking to engage in pro-cyclical investment behaviour.454

The Amendments update the EU’s position on the VA in several respects. The key amendments to the VA are as follows:455

  • Making the use of the VA subject to prior supervisory approval. Such approval will be granted where (i) the RFR does not include an MA for the given portfolio of liabilities, and (ii) the undertaking has adequate processes in place to calculate the VA. Undertakings that have previously applied the VA to the RFR to calculate the BEL will be able to continue to do so (without seeking approval), provided they are compliant with the two aforementioned conditions.
  • Increasing the general application ratio from 65% to 85% such that a higher percentage of the “risk-corrected currency spread” derived from the representative portfolios will be taken into account for the VA.
  • Introduction of an undertaking specific “credit spread sensitivity ratio” in the calculation of the VA.
  • Introduction of an undertaking specific adjustment to the “risk-corrected currency spread” in an amount equal to the lower of 105% and the ratio of risk-corrected spread calculated based on an undertaking’s investments in debt and risk-corrected spread calculated on a reference portfolio. The use of this undertaking specific adjustment will be subject to the following conditions: 456
    • Prior approval from the supervisory authority.
    • The risk-corrected spread calculated on a reference portfolio must exceed the risk-corrected spread calculated based on an undertaking’s investments in debt for four quarterly reporting periods prior to the reporting period.
    • The macro VA (discussed below) will not apply when using the undertaking specific adjustment.
    • The undertaking specific adjustment can only be applied to increase the “risk-corrected currency spread” for no more than two consecutive quarterly reporting periods.
  • Replacement of the country component of the VA with a macro VA for member states with the Euro as their currency.

6. Transitional Measure on Technical Provisions

Given the scale and importance of technical provisions, Solvency II provides for a gradual transition on a straight-line basis over a 16-year period for liabilities that were in force prior to the introduction of Solvency II on 1 January 2016.457 The application of this measure requires prior approval from the supervisory authority.458 This is referred to as the transitional measure on technical provisions.

In the UK, the PRA has simplified the TMTP as part of Solvency UK, which will benefit any firm that is granted TMTP permission in the future (including where it is accepting business that already benefits from TMTP, e.g., by portfolio transfer or a 100% reinsurance transaction).459 These reforms will be implemented by (re)insurers by 31 December 2024.460 In summary, the simplifications:

  • Introduce a simplified new default method for calculating TMTP.
  • Permit firms for which the new TMTP method would be inappropriate to continue to use the existing calculation approach with some modifications.
  • Remove the financial resources requirement test.
  • Require all firms to amortise TMTP so that it decreases to zero by the end of the transitional period.
  • Introduce an expectation that firms consider risks to meeting their solvency risk appetite in the medium term due to TMTP run off.
  • Allow firms to calculate TMTP at the final day of each reporting period and remove the requirement for firms to seek the PRA’s permission for a recalculation.
  • Remove the expectation for TMTP calculations to have audit committee sign-off.
  • Introduce a more consistent approach to TMTP methodology changes where business is transferred or 100% reinsured.
  • Only grant any new permissions to apply TMTP in circumstances where a firm without an existing TMTP permission acquires or accepts business that already benefits from TMTP.
  • Remove the ability for third country branches to use TMTP.

_______________

417 Article 76(2) of the Solvency II Directive.

418 Article 76(1), ibid (transposed in Paragraph 3.1, Technical Provisions Part of the PRA Rulebook).

419 (1) PRA PS25/19; (2) PRA SS23/15, (3) PRA SS5/14; (4) PRA SS6/16; and (5) PRA SS7/18.

420 Article 77(2) of the Solvency II Directive (transposed in Paragraph 3.1, Technical Provisions Part of the PRA Rulebook).

421 Ibid.

422 Article 77(2), ibid (transposed in Paragraph 3.2, Technical Provisions Part of the PRA Rulebook).

423 Article 28 of the Level 2 Delegated Regulation.

424 Article 30, ibid.

425 Article 31, ibid.

400 Article 32, ibid.

427 Chapter III, Subsections 2 and 3, ibid.

428 Article 34(1), ibid.

429 Article 23(1), ibid.

430 Chapter III, Section 4, ibid.

431 Article 77a of the Solvency II Directive (transposed in Paragraph 5.1, Technical Provisions Part of the PRA Rulebook).

432 Article 1(39) 2021/0295 (COD).

433 Ibid

434 Ibid.

435 Ibid.

436 Article 43(1) of the Level 2 Delegated Regulation.

437 Article 77(3) of the Solvency II Directive (transposed in Paragraph 4.2, Technical Provisions Part of the PRA Rulebook).

438 Article 39 of the Level 2 Delegated Regulation.

439 Article 37, ibid.

440 Article 39, ibid.

441 Insurance and Reinsurance Undertakings (Prudential Requirements) (Risk Margin) Regulations 2023.

442 Article 1(38) 2021/0295 (COD).

443 Article 38 of the Level 2 Delegated Regulation.

444 Article 77(4) of the Solvency II Directive (transposed in Paragraph 2.5, Technical Provisions Part of the PRA Rulebook).

445 Article 40 of the Level 2 Delegated Regulation.

446 Article 17, ibid.

447 Article 18, ibid.

448 The EIOPA Level 3 Guidelines clarify the meaning of “unilateral right” in this context. See Guideline 2 of the EIOPA Guidelines on Contract Boundaries (EIOPA-BoS-14/165).

449 Articles 77d to 77e of the Solvency II Directive (transposed in (i) Regulation 43 of the Solvency 2 Regulations; (ii) Paragraphs 8.1 to 8.5, Technical Provisions Part of the PRA Rulebook); Articles 49 to 51 of the Level 2 Delegated Regulation.

450 Article 77d of the Solvency II Directive.

451 Article 77e, ibid.

452 PRA Statement of Policy “The PRA’s Approach to the Publication of Solvency II Technical Information” published in September 2022.

453 Article 77d(5) of the Solvency II Directive (transposed in 8.5 Technical Provisions Part of the PRA Rulebook).

454 (1) PRA SS23/15; and (2) Regulation 43(4) of the Solvency 2 Regulations 2015.

455 Article 1(41) 2021/0295 (COD).

456 Ibid.

457 Article 308d of the Solvency II Directive.

458 Article 308d(1), ibid (transposed in Paragraph 11.1, Transitional Measure Part of the PRA Rulebook).

459 (1) PRA PS2/24; and (2) PRA SS 17/15.

460 Ibid.

This memorandum is provided by Skadden, Arps, Slate, Meagher & Flom LLP and its affiliates for educational and informational purposes only and is not intended and should not be construed as legal advice. This memorandum is considered advertising under applicable state laws.

BACK TO TOP